1-228157745-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_StrongBP6_Moderate
The NM_020435.4(GJC2):c.-14G>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.21 ( 0 hom., cov: 0)
Exomes 𝑓: 0.16 ( 3789 hom. )
Failed GnomAD Quality Control
Consequence
GJC2
NM_020435.4 5_prime_UTR
NM_020435.4 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.278
Genes affected
GJC2 (HGNC:17494): (gap junction protein gamma 2) This gene encodes a gap junction protein. Gap junction proteins are members of a large family of homologous connexins and comprise 4 transmembrane, 2 extracellular, and 3 cytoplasmic domains. This gene plays a key role in central myelination and is involved in peripheral myelination in humans. Defects in this gene are the cause of autosomal recessive Pelizaeus-Merzbacher-like disease-1. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 1-228157745-G-C is Benign according to our data. Variant chr1-228157745-G-C is described in ClinVar as [Benign]. Clinvar id is 402901.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr1-228157745-G-C is described in Lovd as [Benign].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GJC2 | NM_020435.4 | c.-14G>C | 5_prime_UTR_variant | 2/2 | ENST00000366714.3 | NP_065168.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00 AC: 10434AN: 48694Hom.: 0 Cov.: 0 FAILED QC
GnomAD3 genomes
AF:
AC:
10434
AN:
48694
Hom.:
Cov.:
0
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.161 AC: 106630AN: 662238Hom.: 3789 Cov.: 21 AF XY: 0.172 AC XY: 58290AN XY: 338530
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
106630
AN:
662238
Hom.:
Cov.:
21
AF XY:
AC XY:
58290
AN XY:
338530
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR;InbreedingCoeff AF: 0.214 AC: 10437AN: 48658Hom.: 0 Cov.: 0 AF XY: 0.201 AC XY: 4810AN XY: 23878
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR;InbreedingCoeff
AF:
AC:
10437
AN:
48658
Hom.:
Cov.:
0
AF XY:
AC XY:
4810
AN XY:
23878
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at